Nijhawan Pardeep 4
4 · Edesa Biotech, Inc. · Filed Jun 16, 2026
Research Summary
AI-generated summary of this filing
Edesa Biotech (EDSA) CEO Pardeep Nijhawan Buys 153,550 Shares
What Happened
Pardeep Nijhawan, CEO of Edesa Biotech (EDSA), acquired 153,550 common shares on June 16, 2026. The Form 4 reports the acquisition at $5.21 per share for an aggregate purchase price of $799,995.50 (rounded to $799,996). The transaction is reported on Form 4 as code "A" (grant/award/other acquisition) but a footnote clarifies this was a private placement purchase.
Key Details
- Transaction date: June 16, 2026
- Shares acquired: 153,550 at $5.21 per share
- Total cost reported: $799,995.50 (rounded to $799,996)
- Form transaction code: A (footnote states a private placement purchase)
- Shares owned after the transaction: not specified in the filing
- Notable footnotes:
- F1: Confirms the private placement purchase and exact aggregate price.
- F2 & F3: Several entities (two corporations and one trust) are related to Nijhawan; he disclaims beneficial ownership of securities held by those entities except to the extent of his pecuniary interest.
- Timeliness: Filed on the same date as the transaction (no late filing indicated).
Context
This was a direct private placement purchase (not an open-market trade), which can signal insider participation in a company financing or selective share issuance; however, the filing provides no details about resale restrictions, lock-ups, or the issuer's financing terms. As always, purchases are factual signals of insider buying but do not alone guarantee future stock performance.
Insider Transaction Report
- Award
Common Shares
[F1]2026-06-16$5.21/sh+153,550$799,996→ 884,684 total
- 402,702(indirect: Held by Pardeep Nijhawan Medicine Professional Corporation)
Common Shares
[F2] - 32,609(indirect: By Trust)
Common Shares
[F3] - 32,013(indirect: Held by The Digestive Health Clinic Inc.)
Common Shares
[F2] - 53,104(indirect: Held by 1968160Ontario Inc.)
Common Shares
[F2]
Footnotes (3)
- [F1]On June 16, 2026, the Reporting Person purchased in a private placement, 153,550 shares of the Issuer's common shares, at a purchase price of $5.21 per share, for an aggregate purchase price of $799,995.50.
- [F2]Each of Pardeep Medicine Professional Corporation, The Digestive Health Clinic Inc. and 1968160 Ontario Inc. are wholly-owned by Reporting Person. Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F3]Reporting Person is a co-trustee of The New Nijhawan Family Trust 2015. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.